Bergen Brunswig supply channel cost-control is focus after merger called off.
This article was originally published in The Tan Sheet
Executive Summary
BERGEN SUPPLY EFFICIENCIES WILL REMAIN FOCUS AFTER COLLAPSE OF IVAX MERGER agreement, the wholesaler commented March 20. "One of Bergen Brunswig's central strategies is to pursue opportunities to manage supply channel costs" through in-house programs, alliances or acquisitions, Bergen said. "Notwithstanding the termination of the Ivax agreement, we will continue to pursue our strategy, recognizing the valuable role that generics play."